The ASX 200 clawed back ground after setting a new 20-day low and gained around .15 of a per cent.
IT had a strong run, the sector was up more than 1.6 per cent, followed by financials, whilst healthcare fell behind - and shed around 1.7 per cent.
Green
Anteris Technologies shot up after securing FDA approval to begin its global PARADIGM trial of the DurAVR heart valve in severe aortic stenosis — a major step toward U.S. approval for its next-generation transcatheter valve.
Alkane Resources was also up on intercepting more high-grade gold at its Tomingley operations in NSW — including hits of up to 22.8 grams per tonne.
Red
Northern Star Resources and Evolution Mining shed around 2.5 per cent after the price of gold pulled back, despite having no news.
#ASX200 #StockMarketUpdate #TechStocks #GoldStocks #RareEarths #MiningStocks #GoldPullback